News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Job Trends
DMD Setback Prompts Sarepta to Shutter West Coast Location and Consolidate to Massachusetts, 30 Jobs Gone
March 9, 2016
·
3 min read
Policy
With Snowmageddon Predicted for East Coast, FDA Postpones Meeting Over Sarepta’s DMD Drug
January 21, 2016
·
2 min read
Policy
FDA Turns Down Both BioMarin and Sarepta’s DMD Drug Applications, Stocks Plunge
January 15, 2016
·
3 min read
Business
Checkmate Comes Out of Stealth Mode With $20 Million and Ex-Sarepta Exec as Its Leader
August 12, 2015
·
3 min read
Policy
Investors Gear Up For Exciting News as FDA Sets Dates for BioMarin and Sarepta DMD Drugs
July 21, 2015
·
2 min read
Deals
Sarepta and BioMarin Rivalry Heats Up as Sarepta Shops for Second DMD Drug
July 14, 2015
·
3 min read
Business
Sarepta Bags Ex-Genzyme CEO as Advisor to the Company
July 1, 2015
·
6 min read
Policy
New Sarepta CEO’s Strategy Bears Fruit With NDA Filing
June 30, 2015
·
5 min read
Business
EXCLUSIVE: Sarepta’s Interim CEO Doing Well Enough to Be Considered a Permanent Candidate, Company Tells BioSpace
June 2, 2015
·
7 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Sarepta Therapeutics and Selecta Biosciences Enter into Research License and Option Agreement for Selecta’s ImmTOR Immune Tolerance Platform in Neuromuscular Diseases
June 18, 2020
·
12 min read
Genetown
Sarepta Therapeutics Announces Positive Safety and Efficacy Data from the SRP-9001 Micro-Dystrophin Gene Therapy Trial Published in JAMA Neurology
June 15, 2020
·
8 min read
Genetown
Sarepta Therapeutics Announces Positive Expression and Functional Data From the SRP-9003 Gene Therapy Trial to Treat Limb-Girdle Muscular Dystrophy Type 2E
June 8, 2020
·
10 min read
Genetown
Sarepta Therapeutics to Share Clinical Update from SRP-9003 Gene Therapy Trial to Treat Limb-girdle Muscular Dystrophy Type 2E, or Beta-Sarcoglycanopathy
June 5, 2020
·
2 min read
Genetown
Sarepta Therapeutics to Present at Upcoming Investor Conferences
June 2, 2020
·
1 min read
Business
Personalis Announces Scientific Collaboration with Sarepta Therapeutics on Immune Response to Precision Genetic Therapeutics
June 2, 2020
·
2 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 29, 2020
May 29, 2020
·
2 min read
Genetown
Sarepta Therapeutics to Present at the 2020 RBC Capital Markets Virtual Global Healthcare Conference
May 12, 2020
·
1 min read
Business
Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases
May 11, 2020
·
8 min read
Business
Sarepta Therapeutics Announces First Quarter 2020 Financial Results and Recent Corporate Developments
May 6, 2020
·
25 min read
